← Back to Search

Mobile Tech & Peer Health Coaching for Pregnant Black Teens

N/A
Waitlist Available
Led By Abigail Gamble, PhD, MS
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up perceptions of appropriateness at study month 30 (of 36 months).
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve the health of rural pregnant Black teens by leveraging mobile tech and training WIC moms to provide health coaching in a telehealth setting.

Who is the study for?
This trial is for Black or African American adolescent moms aged 15-18 years, who are more than six months postpartum, enrolled in WIC, speak English, and have at least a high school diploma or GED. They aim to help these young women improve their health after pregnancy.
What is being tested?
#BabyLetsMove and Peer Health Coaching are being tested as digital health interventions to support pregnant Black adolescents in the Mississippi Delta. The goal is to reduce risks of cardiometabolic diseases by addressing social barriers and promoting healthy behaviors.
What are the potential side effects?
Since this trial involves lifestyle interventions like physical activity guidance and peer coaching rather than medications, there aren't typical side effects. However, participants may experience changes in daily routines or increased time commitments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~perceptions of appropriateness at study month 30 (of 36 months).
This trial's timeline: 3 weeks for screening, Varies for treatment, and perceptions of appropriateness at study month 30 (of 36 months). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Appropriateness
Intensity coaching session length
+2 more
Secondary study objectives
Moderate-to-vigorous physical activity (MVPA)
Sedentary behavior (SB)
Other study objectives
Glucose variability
Mean arterial pressure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: #BabyLetsMoveExperimental Treatment1 Intervention
There are four digital components to the intervention including Fitbit activity tracker, interactive self-monitoring and tailored feedback text messages, tailored skills training text messages and materials, and peer health coaching.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
#BabyLetsMove
2021
N/A
~20

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
438 Previous Clinical Trials
1,379,386 Total Patients Enrolled
3 Trials studying Gestational Weight Gain
515 Patients Enrolled for Gestational Weight Gain
University of Mississippi Medical CenterLead Sponsor
180 Previous Clinical Trials
196,871 Total Patients Enrolled
1 Trials studying Gestational Weight Gain
144 Patients Enrolled for Gestational Weight Gain
Mississippi State Department of HealthOTHER_GOV
6 Previous Clinical Trials
1,559 Total Patients Enrolled
Health Resources and Services Administration (HRSA)FED
85 Previous Clinical Trials
151,633 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
297 Previous Clinical Trials
248,985 Total Patients Enrolled
2 Trials studying Gestational Weight Gain
180 Patients Enrolled for Gestational Weight Gain
Abigail Gamble, PhD, MSPrincipal InvestigatorUniversity of Mississippi Medical Center
3 Previous Clinical Trials
552 Total Patients Enrolled

Media Library

#BabyLetsMove Clinical Trial Eligibility Overview. Trial Name: NCT05843903 — N/A
Gestational Weight Gain Research Study Groups: #BabyLetsMove
Gestational Weight Gain Clinical Trial 2023: #BabyLetsMove Highlights & Side Effects. Trial Name: NCT05843903 — N/A
#BabyLetsMove 2023 Treatment Timeline for Medical Study. Trial Name: NCT05843903 — N/A
~13 spots leftby May 2026